High-throughput functional virology for human health
Our mission is to make a positive impact on human health as virologists.
Located in New York City at the Columbia University Irving Medical Center, the Iketani Lab is focused on contributing to answering foundational basic and translational virology questions, particularly through high-throughput scalable strategies. The Lab has a strong focus on advancing new approaches that could make an impact in virology and beyond. While we focus on several viruses and specific topics, our hope is that what we develop can be broadly applicable.
Recent Lab News
May 19, 2026
Work from the Lab on elucidating SARS-CoV-2 resistance pathways to atilotrelvir, ibuzatrelvir, and simnotrelvir is published in Nature Communications! This work identified significant cross-resistance against 3CL protease inhibitors among selected viruses, raising an important point of consideration during COVID-19 treatment, as well as highlighting the need for further compound development.
Jul. 1, 2026
Farah is off to graduate school — we will miss you and good luck!
Jul. 29, 2026
A study from the Lab on SARS-CoV-2 resistance pathways to EDP-235 is published in Antiviral Research! This work was a collaborative effort with Enanta Pharmaceuticals, and identified the key mutations involved in resistance to this compound.